Financial News
Latest News about LLY
Recent news which mentions LLY
From Benzinga
Trade Pulse Power Inflow Alert: Eli Lilly Stock Rises Over 7 Points
September 04, 2024
Tickers
LLY
From Benzinga
Despite Medicare Negotiations, Americans May Still Have To Pay More For Prescription Drugs
September 03, 2024
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
September 03, 2024
From Benzinga
Eli Lilly Launches Discounted Mounjaro And Zepbound As Fight Against Compounded Imitations Escalates Amid Ongoing FDA Shortage Status Debate
September 02, 2024
From Benzinga
2 No-Brainer Growth Stocks to Buy With $1,000 Right Now
September 01, 2024
From Motley Fool
3 No-Brainer Stocks to Buy in September
August 31, 2024
From Motley Fool
From Motley Fool
From Motley Fool
From Benzinga
Novo Nordisk Touts Encouraging Wegovy Data To Lower Risk Of Severe Complications In Heart Failure Patients
August 30, 2024
From Benzinga
Tickers
LLY
From Motley Fool
From Motley Fool
Why Hims & Hers Health Stock Was Falling This Week
August 29, 2024
From Motley Fool
Decoding Eli Lilly's Options Activity: What's the Big Picture?
August 29, 2024
Tickers
LLY
From Benzinga
From Motley Fool
From Benzinga
Warren Buffett's Berkshire Hathaway Breaks $1 Trillion: Poll Suggests Big Pharma, Not Tech, Is Next Contender
August 28, 2024
From Benzinga
Prediction: Eli Lilly's Latest Move Will Threaten AbbVie Stock
August 28, 2024
From Motley Fool
From Benzinga
Why Viking Therapeutics Stock Got Thrashed on Tuesday
August 27, 2024
From Motley Fool
Why Hims & Hers Stock Crashed on Tuesday
August 27, 2024
From Motley Fool
Regulators Expected To Approve Innovative Schizophrenia Treatment From Bristol Myers, Karuna
August 27, 2024
From Benzinga
Why Hims & Hers Health Stock Is Falling
August 27, 2024
From Benzinga
Tickers
LLY
From Motley Fool
From Benzinga
From Motley Fool
Governments Suing Pharmacy Benefit Managers Over Insulin Prices Have Long Benefited From Their Rebates
August 26, 2024
From Benzinga
Eli Lilly's Alzheimer's Drug Faces UK Agency Block After Biogen's Medicine Rejection Over Cost, Safety
August 26, 2024
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
